Key result
This minisymposium introduction discusses principles for anticoagulant therapy, novel selective coagulation inhibitors, and their effects on inflammation and cancer.
An introduction to a minisymposium discussing novel selective coagulation inhibitors and their mechanisms of action, including effects on inflammation and cancer.
Schulman S (Karolinska Hospital, Stockholm, Sweden). Novel anticoagulant agents: introduction (Minisymposium). J Intern Med 2003; 254: 308–312. In this Minisymposium three principles for anticoagulant therapy are discussed and examples of novel, selective coagulation inhibitors at the stage of advanced clinical trials are given. This introduction attempts to explain the different mechanisms of action on a broad scale, and also includes a brief look at effects on inflammation and cancer.
No takes yet. Share an insight, caveat, or question.
Sam Schulman (2003) conducted a review in Anticoagulant therapy. Novel anticoagulant agents was evaluated. This minisymposium introduction discusses principles for anticoagulant therapy, novel selective coagulation inhibitors, and their effects on inflammation and cancer.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: